Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative?

Gastroenterology

Volumn 116, Issue 5, 1999, Pages 1246-1249

  Campieri, M ^a   Gionchetti, P ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; UNCLASSIFIED DRUG; VSL 3;

BACTERIAL INFECTION; BACTERIUM ADHERENCE; CLINICAL MEDICINE; EDITORIAL; ENTERITIS; GRAM NEGATIVE BACTERIUM; INTESTINE FLORA; LACTOBACILLUS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0032907877     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70029-6     Document Type: Editorial

References (37)

1. RB Sartor Enteric microflora in IBD: pathogens or commensal? Inflam Bowel Dis 3 1997 230 235
2. GL Simon SL Gorbach Intestinal flora in health and disease Gastroenterology 86 1984 174 193
3. L Sutherland J Singleton J Sessions Double-blind, placebo controlled trial of metronidazole in Crohn's disease Gut 32 1991 1071 1075
4. P Rutgeerts K Geboes M Peeters M Hiele F Penninckx R Aerts R Kerremans G Vantrappen Effect of faecal stream divertion on recurrence of Crohn's disease in the neoterminal ileum Lancet 338 1991 771 774
5. GR D'Haens K Geboes M Peeters F Penninckx P Rutgeerts Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 114 1998 771 774
6. RB Sartor Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation 4th ed JB Kirsner RG Shorter Inflammatory bowel disease 1995 Williams & Wilkins Baltimore, MD 96 124
7. R Duchmann I Kaiser E Hermann W Mayet K Ewe K-H Meyer zum Büschenfelde Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol 102 1995 448 455
8. A Macpherson UY Khoo I Forgacs J Philpott-Howard I Bjarnason Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria Gut 38 1996 365 375
9. RB Sartor Insights into the pathogenesis of inflammatory bowel disease provided by new rodent models of spontaneous colitis Iflam Bowel Dis 1 1995 64 75
10. KL Madsen JS Doyle LD Jewell MM Tavernini RN Fedorak Lactobacillus species prevents colitis in interleukin 10 gene–deficent mice Gastroenterology 116 1999 1107 1114
11. GR Gibson MB Roberfroid Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics J Nutr 125 1995 1401 1412
12. M Schultz C Veltkamp LA Dieleman PB Wyrick SL Tonkonogy RB Sartor Continuous feeding of Lactobacillus plantarum attenuates established colitis in interleukin-10 deficient mice (abstr) Gastroenterology 114 1998 A1081
13. R Fabia A Ar'Rajab M-L Johansson R Willén R Andersson G Molin S Bengmark The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid–induced colitis in the rat Scand J Gastroenterol 28 1993 155 162
14. Y Mao S Nobaek B Kasravi D Adawi U Stenram G Molin B Jeppsson The effects of Lactobacillus strains and oat fibre on methotrexate-induced enterocolitis in rats Gastroenterology 111 1996 334 344
15. E Metchnikoff M Chalmers The prolongation of life: optimistic studies 1907 Heinemann London 161 183
16. H Tissier Traitement des infections intestinales par la méthode de la flore bactérienne de l'intestin C R Soc Biol 60 1906 359 361
17. DM Lilly RH Stillwell Probiotics: growth promoting factors produced by microorganisms Science 47 1965 747 748
18. R Fuller Probiotics in human medicine Gut 32 1991 439 442
19. G Schaafsma State of the art concerning probiotic strains in milk products IDF Nutr Newsl 5 1996 23 24
20. YK Lee S Salminen The coming age of probiotics Trends Food Sci Technol 6 1995 241 245
21. ED Wagner T Warner L Roberts J Farmer E Balish Colonization of congenitally immunodeficient mice with probiotic bacteria Infect Immun 65 1997 3345 3351
22. PC MacGillivray HVL Finlay TB Binns Use of lactulose to create a preponderance of lactobacilli in the intestine of bottle-fed infants Scot Med J 4 1959 182 189
23. J Bircher J Muller P Guggenheim UP Haemmerli Treatment of chronic portal-systemic encephalopathy with lactulose (1-4 beta-galactosidofructose) Lancet 1 1966 890 893
24. GR Gibson ER Beatty X Wang JH Cummings Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin Gastroenterology 108 1995 975 982
25. R Fabia A Ar'Rajab ML Johansson R Andersson R Willén B Jeppsson G Molin S Bengmark Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat Digestion 54 1993 248 255
26. C Favier C Neut C Mizon A Cortot JF Colombel J Mizon Fecal β-D-galactosidase production and bifidobacteria are decreased in Crohn's disease Dig Dis Sci 42 1997 817 822
27. M Malin H Suomalainen M Saxelin E Isolauri Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG Ann Nutr Metab 40 1996 137 145
28. JGH Ruseler-van-Embden WR Schouten LMC van Lieshout Pouchitis: result of microbial imbalance? Gut 35 1994 658 664
29. S Videla J Villaseca A Garcia-Lafuente M Antolin E Crespo F Guarner JR Malagelada Dietary inulin prevents distal colitis induced by dextran sulfate sodium (DSS) (abstr) Gastroenterology 114 1998 A1110
30. HP Meijer CFM Welters E Heineman GS Salomons HA Buller J Dekker AWC Einerhand Effect of enteral inulin on the pouch disease activity index and on epithelial gene expression within the ileoanal pouch: a randomized, placebo-controlled crossover study (abstr) Gastroenterology 114 1998 A397
31. BJ Rembacken AM Snelling PM Hawkey ATR Axon A double blind trial of non pathogenic E. coli vs mesalazine for the treatment of ulcerative colits Gut 41 suppl 3 1997 3911
32. W Kruis E Schuts P Fric B Fixa G Judmaier M Stolte Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis Aliment Pharmacol Ther 11 1997 853 858
33. PA Mackowiak The normal microbial flora N Engl J Med 307 1982 83 93
34. S Bengmark Econutrition and health maintenance. A new concept to prevent GI inflammation, ulceration and sepsis Clin Nutr 15 1996 1 10
35. A Venturi P Gionchetti F Rizzello S Peruzzo E Zucconi P Brigidi D Matteuzzi M Campieri Impact on the faecal flora composition of a new probiotic preparation. Preliminary data on maintenance treatment of patients with ulcerative colitis (UC) intolerant or allergic to 5-aminosalicylic acid (5-ASA) Aliment Pharmacol Ther 1999 (in press)
36. P Gionchetti F Rizzello A Venturi D Matteuzzi M Rossi S Peruzzo G Poggioli G Bazzocchi M Campieri Maintenance treatment of chronic pouchitis: a randomized, placebo-controlled, double-blind trial with a new probiotic preparation (abstr) Gastroenterology 114 1998
37. M Campieri P Gionchetti Manipulation of intestinal microflora P Rutgeerts JF Colombel SB Hanauer J Schölmerich Tytgat A VanGossum Advances in inflammatory bowel disease 1999 Kluwer Academic London 297 300